Know Cancer

or
forgot password
  • cancer clinical trials in alabama

  • A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Lymphoma
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Regional Medical Center

    Trial Locations
    Regional Medical Center
    Providence Cancer Center at Providence Hospital
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Providence Hospital
    Mobile, Alabama 36608
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    Birmingham Hematology and Oncology

    Trial Locations
    Birmingham Hematology and Oncology
    Birmingham Hematology and Oncology - Pilot
    Birmingham Hematology and Oncology - Princeton
    Birmingham Hematology and Oncology - Montclair
    Birmingham Hematology and Oncology - Brookwood
    Clearview Cancer Institute- Huntsville
    Breast Cancer
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Children's Hospital of Alabama at University of Alabama at Birmingham

    Trial Locations
    Children's Hospital of Alabama at University of Alabama at Birmingham
    University of South Alabama Mitchell Cancer Institute
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Lymphoma
    S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    University of Alabama at Birmingham/ Kirklin Clinic Comprehensive CancerCenter (1)

    Trial Locations
    University of Alabama at Birmingham/ Kirklin Clinic Comprehensive CancerCenter (1)
    University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst.
    Renal Cell Carcinoma
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Alabaster, Alabama
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Head and Neck Squamous Cell Carcinoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
    GSK Investigational Site
    Birmingham, Alabama 35209
    Leukemia-relapsed or Refractory, Cancer
    Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

    Birmingham, Alabama 35294
    Pain, Burning, Pain, Crushing, Pain, Migratory, Pain, Radiating, Pain, Splitting
    Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Metastatic Childhood Soft Tissue Sarcoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Central Nervous System Embryonal Tumor, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    North Central Neurology Associates, P.C.
    Cullman, Alabama
    Multiple Sclerosis, Relapsing-Remitting
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Prostate Cancer, Sexual Dysfunction
    Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Providence Hospital
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Pioglitazone for Oral Premalignant Lesions
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Oral Leukoplakia
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    University of South Alabama Mitchell Cancer Institute
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    University of South Alabama Mitchell Cancer Institute
    Mobile, Alabama 36604
    Ovarian Cancer, Sarcoma
    Study of Blood Samples From Newborns With Down Syndrome
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia
    Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Non-Small Cell Lung Cancer
    Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Pain, Pancreatic Cancer
    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    Providence Hospital
    Mobile, Alabama 36608
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma